114 related articles for article (PubMed ID: 17563766)
1. Particle therapy in prostate cancer: a review.
Greco C
Prostate Cancer Prostatic Dis; 2007; 10(4):323-30. PubMed ID: 17563766
[TBL] [Abstract][Full Text] [Related]
2. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter.
Vassiliev ON; Kry SF; Kuban DA; Salehpour M; Mohan R; Titt U
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1567-71. PubMed ID: 17544596
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation therapy: supportive data for prostate cancer.
Cahlon O; Hunt M; Zelefsky MJ
Semin Radiat Oncol; 2008 Jan; 18(1):48-57. PubMed ID: 18082588
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
[TBL] [Abstract][Full Text] [Related]
5. Basics of particle therapy: introduction to hadrons.
Welsh JS
Am J Clin Oncol; 2008 Oct; 31(5):493-5. PubMed ID: 18838888
[TBL] [Abstract][Full Text] [Related]
6. Current status of radiotherapy with proton and light ion beams.
Greco C; Wolden S
Cancer; 2007 Apr; 109(7):1227-38. PubMed ID: 17326046
[TBL] [Abstract][Full Text] [Related]
7. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.
Yuen J; Rodrigues G; Trenka K; Coad T; Yartsev S; D'Souza D; Lock M; Bauman G
Radiat Oncol; 2008 Jan; 3():1. PubMed ID: 18179695
[TBL] [Abstract][Full Text] [Related]
8. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
9. Particle radiation therapy using proton and heavier ion beams.
Schulz-Ertner D; Tsujii H
J Clin Oncol; 2007 Mar; 25(8):953-64. PubMed ID: 17350944
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
11. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
12. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation with proton or photon radiation treatment for pancreatic cancer.
Bouchard M; Amos RA; Briere TM; Beddar S; Crane CH
Radiother Oncol; 2009 Aug; 92(2):238-43. PubMed ID: 19454367
[TBL] [Abstract][Full Text] [Related]
14. Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer.
Efstathiou JA; Trofimov AV; Zietman AL
Cancer J; 2009; 15(4):312-8. PubMed ID: 19672148
[TBL] [Abstract][Full Text] [Related]
15. [Robotic radiotherapy for prostate cancer with CyberKnife].
Hannoun-Levi JM; Benezery K; Bondiau PY; Chamorey E; Marcié S; Gerard JP
Cancer Radiother; 2007 Dec; 11(8):476-82. PubMed ID: 17888705
[TBL] [Abstract][Full Text] [Related]
16. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
[TBL] [Abstract][Full Text] [Related]
18. A comparison of conformal and intensity modulated treatment planning techniques for early prostate cancer.
Vaarkamp J; Malde R; Dixit S; Hamilton CS
J Med Imaging Radiat Oncol; 2009 Jun; 53(3):310-7. PubMed ID: 19624299
[TBL] [Abstract][Full Text] [Related]
19. High-dose external beam radiation for localized prostate cancer: current status and future challenges.
Nguyen PL; Zietman AL
Cancer J; 2007; 13(5):295-301. PubMed ID: 17921728
[TBL] [Abstract][Full Text] [Related]
20. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
